{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:51:54Z","timestamp":1774518714628,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100015811","name":"Science and Technology Department of Ningxia Province","doi-asserted-by":"publisher","award":["Key Technologies and Applications of Medical Big Data Management in Major Chronic Diseases (2022BEG02025)"],"award-info":[{"award-number":["Key Technologies and Applications of Medical Big Data Management in Major Chronic Diseases (2022BEG02025)"]}],"id":[{"id":"10.13039\/100015811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"DOI":"10.1186\/s12911-026-03402-7","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:23:49Z","timestamp":1772295829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting adverse prognostic outcomes in hospitalized breast cancer patients: development and validation of a risk model"],"prefix":"10.1186","volume":"26","author":[{"given":"Liya","family":"Ma","sequence":"first","affiliation":[]},{"given":"Endi","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Zhiyuan","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Mengchun","family":"Gong","sequence":"additional","affiliation":[]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"3402_CR1","doi-asserted-by":"crossref","unstructured":"Wu Z, Xia F, Lin R. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 2024;17(1):119.","DOI":"10.1186\/s13045-024-01640-8"},{"key":"3402_CR2","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u2013263.","DOI":"10.3322\/caac.21834"},{"key":"3402_CR3","doi-asserted-by":"crossref","unstructured":"Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond). 2022;83(2):1\u20137.","DOI":"10.12968\/hmed.2021.0459"},{"key":"3402_CR4","doi-asserted-by":"crossref","unstructured":"Jianhui Z, Liying X, Jing S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMI Oncology. 2023;2(1):e000049.","DOI":"10.1136\/bmjonc-2023-000049"},{"key":"3402_CR5","doi-asserted-by":"crossref","unstructured":"Ugai T, Sasamoto N, Lee HY, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19(10):656\u2013673.","DOI":"10.1038\/s41571-022-00672-8"},{"key":"3402_CR6","unstructured":"Huang DQ, Yang M, Xiong W, et al. Analysis of disease burden and attributable risk factors of early-onset female breast cancer in China and globally from 1990 to 2021. J Peking Union Med Coll. 2025;1\u201312."},{"key":"3402_CR7","doi-asserted-by":"crossref","unstructured":"Johnston SRD, Toi M, O'Shaughnessy J, Rastogi P, Campone M, Neven P, Huang CS, Huober J, Jaliffe GG, Cicin I, Tolaney SM, Goetz MP, Rugo HS, Senkus E, Testa L, Del Mastro L, Shimizu C, Wei R, Shahir A, Munoz M, et al.; monarchE Committee Members. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023;24(1):77-90.","DOI":"10.1016\/S1470-2045(22)00694-5"},{"key":"3402_CR8","doi-asserted-by":"publisher","unstructured":"Sheffield KM, Peachey JR, Method M, Grimes BR, Brown J, Saverno K, Sugihara T, Cui ZL, Lee KT. A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer. Future Oncol. 2022;18(21):2667-2682.https:\/\/doi.org\/10.2217\/fon-2022-0310","DOI":"10.2217\/fon-2022-0310"},{"key":"3402_CR9","doi-asserted-by":"crossref","unstructured":"Pereira LC, da Silva SJ, Fidelis CR, Brito AL, Xavier J\u00fanior SFA, Andrade LSDS, de Oliveira MEC, de Oliveira TA. Cox model and decision trees: an application to breast cancer data. Rev Panam Salud Publica. 2022;46:e17.","DOI":"10.26633\/RPSP.2022.17"},{"key":"3402_CR10","doi-asserted-by":"crossref","unstructured":"Huang Q, Yang Y, Yuan C, Zhang W, Zong X, Wu F. Use of machine learning algorithms to construct models of symptom burden cluster risk in breast cancer patients undergoing chemotherapy. Support Care Cancer. 2025;33(3):190.","DOI":"10.1007\/s00520-025-09236-9"},{"key":"3402_CR11","doi-asserted-by":"crossref","unstructured":"Zhou P, Qian H, Zhu P, Ben J, Chen G, Chen Q, Chen L, Chen J, He Y. Machine learning for predicting neoadjuvant chemotherapy effectiveness using ultrasound radiomics features and routine clinical data of patients with breast cancer. Front Oncol. 2025;14:1485681.","DOI":"10.3389\/fonc.2024.1485681"},{"key":"3402_CR12","doi-asserted-by":"crossref","unstructured":"Chufal KS, Ahmad I, Miller AA, et al. Machine learning model for predicting DIBH non-eligibility in left-sided breast cancer radiotherapy: Development, validation and clinical impact analysis. Radiother Oncol. 2025;205:110764.","DOI":"10.1016\/j.radonc.2025.110764"},{"key":"3402_CR13","doi-asserted-by":"crossref","unstructured":"Kallah-Dagadu G, Mohammed M, Nasejje JB, et al. Breast cancer prediction based on gene expression data using interpretable machine learning techniques. Sci Rep. 2025;15(1):7594.","DOI":"10.1038\/s41598-025-85323-5"},{"key":"3402_CR14","doi-asserted-by":"crossref","unstructured":"Huang Q, Yang Y, Yuan C, et al. Use of machine learning algorithms to construct models of symptom burden cluster risk in breast cancer patients undergoing chemotherapy. Support Care Cancer. 2025;33(3):190.","DOI":"10.1007\/s00520-025-09236-9"},{"key":"3402_CR15","doi-asserted-by":"crossref","unstructured":"Clift AK, Dodwell D, Lord S, Petrou S, Brady M, Collins GS, Hippisley-Cox J. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study. BMJ. 2023;381:e073800.","DOI":"10.1136\/bmj-2022-073800"},{"key":"3402_CR16","doi-asserted-by":"crossref","unstructured":"Sammut SJ, Crispin-Ortuzar M, Chin SF, Provenzano E, Bardwell HA, Ma W, Cope W, Dariush A, Dawson SJ, Abraham JE, Dunn J, Hiller L, Thomas J, Cameron DA, Bartlett JMS, Hayward L, Pharoah PD, Markowetz F, Rueda OM, Earl HM, et al. Multi-omic machine learning predictor of breast cancer therapy response. Nature. 2022;601(7894):623-629.","DOI":"10.1038\/s41586-021-04278-5"},{"key":"3402_CR17","doi-asserted-by":"crossref","unstructured":"Kalafi EY, Nor NAM, Taib NA, Ganggayah MD, Town C, Dhillon SK. Machine learning and deep learning approaches in breast cancer survival prediction using clinical data. Folia Biol. 2019;65(5-6):212-220..","DOI":"10.14712\/fb2019065050212"},{"key":"3402_CR18","doi-asserted-by":"crossref","unstructured":"Ganggayah MD, Taib NA, Har YC, Lio P, Dhillon SK. Predicting factors for survival of breast cancer patients using machine learning techniques. BMC Med Inform Decis Mak. 2019;19(1):48.","DOI":"10.1186\/s12911-019-0801-4"},{"key":"3402_CR19","doi-asserted-by":"publisher","unstructured":"Zuo D, Yang L, Jin Y, Qi H, Liu Y, Ren L. Machine learning-based models for the prediction of breast cancer recurrence risk. BMC Med Inform Decis Mak. 2023;23(1):276. https:\/\/doi.org\/10.1186\/s12911-023-02377-z","DOI":"10.1186\/s12911-023-02377-z"},{"key":"3402_CR20","doi-asserted-by":"crossref","unstructured":"Kamble TS, Wang H, Myers N, et al. Predicting cancer survival at different stages: Insights from fair and explainable machine learning approaches. Int J Med Inform. 2025;197:105822.","DOI":"10.1016\/j.ijmedinf.2025.105822"},{"key":"3402_CR21","doi-asserted-by":"crossref","unstructured":"Song X, Chu J, Guo Z, et al. Prognostic prediction of breast cancer patients using machine learning models: a retrospective analysis. Gland Surg. 2024;13(9):1575\u20131587.","DOI":"10.21037\/gs-24-106"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-026-03402-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03402-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:38:23Z","timestamp":1774514303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12911-026-03402-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3402"],"URL":"https:\/\/doi.org\/10.1186\/s12911-026-03402-7","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study included hospitalized patients as the study subjects. The clinical electronic medical record data used in this study belong to Ningxia General Hospital, and the original data are not publicly available. The clinical electronic database is established in strict accordance with the Declaration of Helsinki Principles. The study protocol was approved by the Medical Ethics Committee of General Hospital of Ningxia Medical University(approval number: KYLL-2021-934), which waived the requirement for patient informed consent due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}